TIMOLOL

N/A

Manufactured by Thea Pharma Inc.

19,009 FDA adverse event reports analyzed

Last updated: 2026-04-14

About TIMOLOL

TIMOLOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Thea Pharma Inc.. The most commonly reported adverse reactions for TIMOLOL include TREATMENT FAILURE, DRUG INEFFECTIVE, FATIGUE, HYPERSENSITIVITY, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TIMOLOL.

Top Adverse Reactions

TREATMENT FAILURE3,042 reports
DRUG INEFFECTIVE783 reports
FATIGUE470 reports
HYPERSENSITIVITY456 reports
DIZZINESS401 reports
DIARRHOEA396 reports
OFF LABEL USE395 reports
DYSPNOEA363 reports
NAUSEA347 reports
EYE IRRITATION327 reports
FALL317 reports
HEADACHE301 reports
EYE PAIN279 reports
VISION BLURRED274 reports
INTRAOCULAR PRESSURE INCREASED273 reports
ASTHENIA256 reports
PAIN256 reports
DEATH239 reports
GLAUCOMA231 reports
MALAISE212 reports
OCULAR HYPERAEMIA209 reports
VOMITING208 reports
VISUAL IMPAIRMENT202 reports
CONDITION AGGRAVATED200 reports
ACUTE KIDNEY INJURY188 reports
ARTHRALGIA183 reports
COUGH175 reports
DECREASED APPETITE175 reports
CONSTIPATION174 reports
DRUG HYPERSENSITIVITY172 reports
WEIGHT DECREASED171 reports
PNEUMONIA170 reports
CATARACT169 reports
PAIN IN EXTREMITY166 reports
RASH165 reports
CONFUSIONAL STATE164 reports
PRURITUS163 reports
HYPERTENSION160 reports
EYE PRURITUS148 reports
ANAEMIA147 reports
INSOMNIA147 reports
HYPOTENSION144 reports
BRADYCARDIA142 reports
URINARY TRACT INFECTION136 reports
ANXIETY135 reports
INCORRECT DOSE ADMINISTERED135 reports
FEELING ABNORMAL133 reports
BACK PAIN132 reports
GAIT DISTURBANCE131 reports
PYREXIA131 reports
DRUG INTERACTION129 reports
ERYTHEMA122 reports
LACRIMATION INCREASED122 reports
SOMNOLENCE120 reports
BLOOD PRESSURE INCREASED115 reports
MYALGIA112 reports
DEPRESSION108 reports
DRY EYE108 reports
DRY MOUTH106 reports
PRODUCT DOSE OMISSION ISSUE106 reports
ALOPECIA104 reports
PERIPHERAL SWELLING104 reports
PRODUCT QUALITY ISSUE104 reports
RENAL FAILURE104 reports
DEHYDRATION103 reports
VISUAL ACUITY REDUCED102 reports
CHEST PAIN101 reports
ATRIAL FIBRILLATION100 reports
BLINDNESS99 reports
CHRONIC KIDNEY DISEASE97 reports
PRODUCT USE IN UNAPPROVED INDICATION96 reports
HYPOAESTHESIA94 reports
ABDOMINAL PAIN UPPER92 reports
WEIGHT INCREASED91 reports
ABDOMINAL PAIN87 reports
JOINT SWELLING84 reports
LOSS OF CONSCIOUSNESS84 reports
MUSCLE SPASMS84 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS84 reports
BLOOD GLUCOSE INCREASED83 reports
GASTROINTESTINAL HAEMORRHAGE83 reports
BALANCE DISORDER82 reports
CONTUSION82 reports
OEDEMA PERIPHERAL81 reports
ARTHRITIS78 reports
ABDOMINAL DISCOMFORT76 reports
HAEMOGLOBIN DECREASED75 reports
EYE DISORDER73 reports
MYOCARDIAL INFARCTION73 reports
SYNCOPE72 reports
ASTHMA71 reports
EYE SWELLING71 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION71 reports
MEMORY IMPAIRMENT71 reports
PRODUCT USE ISSUE70 reports
ABDOMINAL DISTENSION69 reports
VERTIGO69 reports
HYPONATRAEMIA68 reports
MUSCULAR WEAKNESS68 reports
TREMOR68 reports

Report Outcomes

Out of 11,691 classified reports for TIMOLOL:

Serious 46.8%Non-Serious 53.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6,467 (58.6%)
Male4,547 (41.2%)
Unknown28 (0.3%)

Reports by Age

Age 72213 reports
Age 77209 reports
Age 74195 reports
Age 75190 reports
Age 76184 reports
Age 73177 reports
Age 84177 reports
Age 78175 reports
Age 71171 reports
Age 81163 reports
Age 80161 reports
Age 64158 reports
Age 79156 reports
Age 69152 reports
Age 85152 reports
Age 70147 reports
Age 68143 reports
Age 82141 reports
Age 83140 reports
Age 86130 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TIMOLOL?

This profile reflects 19,009 FDA FAERS reports that mention TIMOLOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TIMOLOL?

Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, FATIGUE, HYPERSENSITIVITY, DIZZINESS, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TIMOLOL?

Labeling and FAERS entries often list Thea Pharma Inc. in connection with TIMOLOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.